Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Kangzhou Fungi Extract is a China-based manufacturer of mushroom and fungal extracts used in pharmaceuticals, traditional Chinese medicine, health products, and related wellness applications. The company describes itself as an integrated biotech enterprise spanning research and development, cultivation, production, processing, and sales, with its own raw-material garden/cultivation base and extract factory. Its commercial portfolio appears to center on polysaccharide- and triterpene-containing extracts from reishi, maitake, cordyceps, shiitake, coriolus, tremella, hericium, and other medicinal mushrooms. Publicly available information points to a supplier/business-to-business model rather than a clinical-stage therapeutic pipeline, with customers including Chinese drug and health-product manufacturers and exports to multiple international markets. The company appears to operate as a commercial ingredients and extracts business rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Kangzhou Fungi Extract.